GROUP 2 PULMONARY HYPERTENSION
Clinical trials for GROUP 2 PULMONARY HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new GROUP 2 PULMONARY HYPERTENSION trials appear
Sign up with your email to follow new studies for GROUP 2 PULMONARY HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart failure drug study pulled before starting
Disease control TerminatedThis study was designed to test the safety and tolerability of a drug called JK07 in people with heart failure and a specific type of high blood pressure in the lungs. It planned to enroll 20 to 30 adults aged 18 to 85. However, the study was withdrawn before any participants wer…
Matched conditions: GROUP 2 PULMONARY HYPERTENSION
Phase: PHASE2 • Sponsor: Salubris Biotherapeutics Inc • Aim: Disease control
Last updated May 17, 2026 02:59 UTC
-
Could a common ED drug help lung hypertension patients walk farther?
Disease control OngoingThis study tests whether tadalafil, a drug often used for erectile dysfunction, can help people with group 2 pulmonary hypertension (high blood pressure in the lungs). 48 participants will take tadalafil or a placebo for 12 weeks. The main goal is to see if the drug improves how …
Matched conditions: GROUP 2 PULMONARY HYPERTENSION
Phase: NA • Sponsor: Beni-Suef University • Aim: Disease control
Last updated May 11, 2026 20:39 UTC